Micro balloon catheter sales will rise through 2036, driven by coronary artery diseases at a 36.8% share in 2026 as the leading indication segment. The market was valued at USD 315.60 million in 2025 and is expected to reach USD 485.85 million by 2036, creating an incremental opportunity of USD 157.63 million.